The US Food and Drug Administration (FDA) has issued warning letters to two herbal medicine companies telling them to stop trying to sell products which they allege are effective against the coronavirus.
Colorado-based Prairie Dawn Herbs was warned after the FDA investigated its website and social media sites and learned the company was selling products it claimed could protect the immune system and combat symptoms of Covid-19, the FDA said in a news release Friday.
“Based on our review, this product is an unapproved new drug under section 505 of the Federal Food, Drug, and Cosmetic Act,” the agency wrote in a warning letter it sent the company Wednesday. “Furthermore, this product is a misbranded drug."
The FDA cited a monthly newsletter posted to the company’s website offering 20% off several herbal products (Chest Tea, Echinacea Tincture, Mentholated Salve, Eucalyptus Oil, Thieves Oil and Echinacea Glycerite) for the duration of the outbreak “due to the continued threat of COVID-19.”
The FDA also warned Griffo Botanicals for selling herbal tincture products it said could treat symptoms of Covid-19.
There are no FDA-approved products to prevent or treat coronavirus. One antiviral drug, remdesivir, has emergency use authorization for treatment but must be used in a hospital under physician supervision.
The FDA says that until the companies took corrective action, they would be on a list of firms and websites that have received warning letters from the FDA “concerning the sale or distribution of COVID-19 related products.”
As of Friday afternoon, the COVID-19 Special was still available for purchase on the Prairie Dawn Herbs website. There was no mention of Covid-19 treatments on the Griffo Botanicals website.